AV

Atlas Venture Associates IX, LLC

Concentrated strategySector-focusedLong-term holder

Total reported value

$631.0M

Reporting period: 2020-12-31 · Number of holdings: 7

Atlas Venture Associates IX, LLC disclosed 7 holdings in its latest 13F filing for the period ending 2020-12-31, with total reported value of $631.0M and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
100
Diversification
14
Sizing Uniformity
81.36

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Skillz INCStock-Other73.80%
2NTLAIntellia Therapeutics INCStock-Other13.93%
3SURFUSDSurface Oncology INCStock-Other4.31%
4SPROSpero Therapeutics INCStock-Other4.23%
5COGTCogent Biosciences INCStock-Other1.63%
6SNAPSnap INC - AStock-Comm Services1.19%
7Synlogic INCStock-Other0.91%

Holding changes this quarter

Position changes disclosed by Atlas Venture Associates IX, LLC for the quarter ending 2020-12-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Atlas Venture Associates IX, LLC and what type of investor is it?
Atlas Venture Associates IX, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2020-12-31), the firm manages a tracked equity portfolio valued at approximately $631.0M, spread across 7 disclosed positions.
What are Atlas Venture Associates IX, LLC's largest equity positions?
Based on the latest 13F filing, Atlas Venture Associates IX, LLC's top holdings by market value are: 1. Skillz INC — $465.7M (73.8%) 2. Intellia Therapeutics INC (NTLA) — $87.9M (13.9%) 3. Surface Oncology INC (SURFUSD) — $27.2M (4.3%) 4. Spero Therapeutics INC (SPRO) — $26.7M (4.2%) 5. Cogent Biosciences INC (COGT) — $10.3M (1.6%)
What changes did Atlas Venture Associates IX, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Atlas Venture Associates IX, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Atlas Venture Associates IX, LLC focus on?
Atlas Venture Associates IX, LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Communication Services: 100.0%